Abiopharma

🔍 SC US (TTGP), LTD. (Executive)

Company: Ethos Technologies Inc. (LIFE)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 19,349 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: C | equity_swap_involved: 0 | shares_owned_after: 19,349.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 15,472 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: C | equity_swap_involved: 0 | shares_owned_after: 15,472.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 19,349 shares of Class A Common Stock at $32.8215 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F2
• Sold 15,472 shares of Class A Common Stock at $32.8215 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F2
• Acquired 59,897 shares of Class A Common Stock (Direct)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | shares_owned_after: 59,897.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 47,898 shares of Class A Common Stock (Direct)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | shares_owned_after: 47,898.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 19,924 shares of Class A Common Stock at $32.522 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 39,973.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 15,933 shares of Class A Common Stock at $32.522 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,965.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 37,250 shares of Class A Common Stock at $33.3745 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,723.00 | transaction_form_type: 4 | Footnotes: F6, F2
• Sold 29,788 shares of Class A Common Stock at $33.3745 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,177.00 | transaction_form_type: 4 | Footnotes: F6, F2
• Sold 2,723 shares of Class A Common Stock at $34.0517 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F7, F2
• Sold 2,177 shares of Class A Common Stock at $34.0517 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F7, F2
• Sold 19,349 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: C | equity_swap_involved: 0 | shares_owned_after: 59,897.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 15,472 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: C | equity_swap_involved: 0 | shares_owned_after: 47,898.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 59,897 shares of Class B Common Stock (Derivative)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 47,898 shares of Class B Common Stock (Derivative)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Holds 6,823,189 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 6,823,189.00 | Footnotes: F1, F1, F1, F8
• Holds 287,297 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 287,297.00 | Footnotes: F1, F1, F1, F8
• Holds 103,310 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 103,310.00 | Footnotes: F1, F1, F1, F8
• Holds 1,052,540 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 1,052,540.00 | Footnotes: F1, F1, F1, F8
• Holds 1,812,546 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 1,812,546.00 | Footnotes: F1, F1, F1, F8

Footnotes:

• F1: The Issuer's Class B Common Stock is convertible into the Issuer's Class A Common Stock on a one-for-one basis at the option of the holder thereof and has no expiration date.
• F2: SC US SSF 2013 (TTGP), L.L.C. is the general partner of SC U.S. Scout Seed Fund 2013 Management, L.P., which is the general partner of Sequoia Capital U.S. Scout Seed Fund 2013, L.P., which wholly owns Sequoia Capital U.S. Scout Fund IV, L.L.C., which in turn wholly owns Nalrena, L.L.C. and Spelunker Channel Holdings, LLC (collectively, the Scout Funds). As a result, SC US SSF 2013 (TTGP), L.L.C., SC U.S. Scout Seed Fund 2013 Management, L.P., Sequoia Capital U.S. Scout Seed Fund 2013, L.P., and Sequoia Capital U.S. Scout Fund IV, L.L.C. may be deemed to share voting and dispositive power with respect to the shares held by the Scout Funds.
• F3: [continued from Footnote 2] Each of SC US SSF 2013 (TTGP), L.L.C., SC U.S. Scout Seed Fund 2013 Management, L.P., Sequoia Capital U.S. Scout Seed Fund 2013, L.P., and Sequoia Capital U.S. Scout Fund IV, L.L.C. disclaims beneficial ownership of the securities held by the Scout Funds except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.2472 to $33.0547, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), (6) and (7) to this Form 4.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.8450 to $32.8350, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.8450 to $33.8400, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.8750 to $34.1961, inclusive.
• F8: SC US (TTGP), Ltd. is (i) the general partner of SC U.S. Growth VIII Management, L.P., which is the general partner of Sequoia Capital U.S. Growth Fund VIII, L.P. (GFVIII), and (ii) the general partner of SC U.S. Venture XV Management, L.P., which is the general partner of Sequoia Capital U.S. Venture Fund XV, L.P., Sequoia Capital U.S. Venture Partners Fund XV (Q), L.P., Sequoia Capital U.S. Venture Partners Fund XV, L.P., and Sequoia Capital U.S. Venture XV Principals Fund, L.P. (collectively, the XV Funds).
• F9: [continued from Footnote 8] As a result, SC US (TTGP), Ltd. may be deemed to share voting and dispositive power with respect to the shares held by GFVIII and the XV Funds. Each of SC US (TTGP), Ltd., SC U.S. Growth VIII Management, L.P. and SC U.S. Venture XV Management, L.P. disclaims beneficial ownership of the shares held by GFVIII and the XV Funds, as applicable, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
• REMARKS: 2 of 2